By Edward Winnick and Tony Fong

SAN FRANCISCO (GenomeWeb News) – The second day of the JP Morgan Conference included presentations from several of molecular tools and molecular diagnostics bellwethers, including Thermo Fisher Scientific and Qiagen, as well as single-molecule sequencing firm Pacific Biosciences.

Below is a recap of their pitches to investors and other issues discussed during their breakout sessions.

Thermo Fisher Scientific

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US Attorney General Jeff Sessions is considering using DNA tests to determine relatedness between adult and child migrants, the Daily Caller reports.

Bloomberg reports that Brainstorm Cell Therapeutics plans to offer a treatment it is developing under the "right to try" law for hundreds of thousands of dollars.

In Nature this week: expansion of disease-resistance genes among long-lived oak trees, and more.

In a proof-of-concept study, researchers report being able to determine age from dried bloodstains, Discover's D-brief blog reports.